Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives As Potential Anticancer Agents Targeting MMP-9

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2017 Jul 6

PMID 28677624

Citations 8

Authors

Ahmet Ozdemir

Belgin Sever

Mehlika Dilek Altintop

Halide Edip Temel

Ozlem Atli

Merve Baysal

Fatih Demirci

Affiliations

Soon will be listed here.

Abstract

Matrix metalloproteinases (MMPs) are important proteases involved in tumor progression including angiogenesis, tissue invasion, and migration. Therefore, MMPs have been reported as potential diagnostic and prognostic biomarkers in many types of cancer. New oxadiazole, thiadiazole, and triazole derivatives were synthesized and evaluated for their anticancer effects on A549 human lung adenocarcinoma and C6 rat glioma cell lines. In order to examine the relationship between their anticancer activity and MMP-9, the compounds were evaluated for their inhibitory effects on MMPs. -(1,3-Benzodioxol-5-ylmethyl)-2-{[5,[5-(((5,6,7,8-tetrahydronaphthalen-2-yl)oxy)methyl)-1,3,4-oxadiazol-2-yl]thio}acetamide () and -(1,3-benzodioxol-5-ylmethyl)-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)thio]acetamide () revealed promising cytotoxic effects on A549 and C6 cell lines similar to cisplatin without causing any toxicity towards NIH/3T3 mouse embryonic fibroblast cell line. Compounds and were also the most effective MMP-9 inhibitors in this series. Moreover, docking studies pointed out that compounds and had good affinity to the active site of the MMP-9 enzyme. The molecular docking and in vitro studies suggest that the MMP-9 inhibitory effects of compounds and may play an important role in lung adenocarcinoma and glioma treatment.

Citing Articles

Identification of Novel β-Tubulin Inhibitors Using a Combined / Approach.

Horgan M, Zell L, Siewert B, Stuppner H, Schuster D, Temml V J Chem Inf Model. 2023; 63(20):6396-6411.

PMID: 37774242 PMC: 10598795. DOI: 10.1021/acs.jcim.3c00939.

Synthesis of New Bioactive Indolyl-1,2,4-Triazole Hybrids As Dual Inhibitors for EGFR/PARP-1 Targeting Breast and Liver Cancer Cells.

Youssef M, Nafie M, Salama E, Boraei A, Gad E ACS Omega. 2022; 7(49):45665-45677.

PMID: 36530255 PMC: 9753112. DOI: 10.1021/acsomega.2c06531.

Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anticancer agents.

Emami L, Sadeghian S, Mojaddami A, Khabnadideh S, Sakhteman A, Sadeghpour H BMC Chem. 2022; 16(1):91.

PMID: 36369166 PMC: 9652805. DOI: 10.1186/s13065-022-00887-x.

Comparative Study of the Synthetic Approaches and Biological Activities of the Bioisosteres of 1,3,4-Oxadiazoles and 1,3,4-Thiadiazoles over the Past Decade.

El-Masry R, Kadry H, Taher A, Abou-Seri S Molecules. 2022; 27(9).

PMID: 35566059 PMC: 9102899. DOI: 10.3390/molecules27092709.

Exploring the Synergistic Anticancer Potential of Benzofuran-Oxadiazoles and Triazoles: Improved Ultrasound- and Microwave-Assisted Synthesis, Molecular Docking, Hemolytic, Thrombolytic and Anticancer Evaluation of Furan-Based Molecules.

Irfan A, Faiz S, Rasul A, Zafar R, Zahoor A, Kotwica-Mojzych K Molecules. 2022; 27(3).

PMID: 35164286 PMC: 8838991. DOI: 10.3390/molecules27031023.

References

Altintop M, Ozdemir A, Turan-Zitouni G, Ilgin S, Atli O, Iscan G . Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents. Eur J Med Chem. 2012; 58:299-307. DOI: 10.1016/j.ejmech.2012.10.011. View

Gaspar D, Veiga A, Castanho M . From antimicrobial to anticancer peptides. A review. Front Microbiol. 2013; 4:294. PMC: 3787199. DOI: 10.3389/fmicb.2013.00294. View

Juszczak M, Matysiak J, Szeliga M, Pozarowski P, Niewiadomy A, Albrecht J . 2-Amino-1,3,4-thiadiazole derivative (FABT) inhibits the extracellular signal-regulated kinase pathway and induces cell cycle arrest in human non-small lung carcinoma cells. Bioorg Med Chem Lett. 2012; 22(17):5466-9. DOI: 10.1016/j.bmcl.2012.07.036. View

Decock J, Thirkettle S, Wagstaff L, Edwards D . Matrix metalloproteinases: protective roles in cancer. J Cell Mol Med. 2011; 15(6):1254-65. PMC: 4373327. DOI: 10.1111/j.1582-4934.2011.01302.x. View

Xiao Q, Zhang F, Lin L, Fang C, Wen G, Tsai T . Functional role of matrix metalloproteinase-8 in stem/progenitor cell migration and their recruitment into atherosclerotic lesions. Circ Res. 2012; 112(1):35-47. DOI: 10.1161/CIRCRESAHA.112.274019. View

Roy R, Yang J, Moses M . Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009; 27(31):5287-97. PMC: 2773480. DOI: 10.1200/JCO.2009.23.5556. View

Shon S, Kim A, Kim J, Kim K, Yang Y, Lim J . Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem Biophys Res Commun. 2009; 385(2):198-203. DOI: 10.1016/j.bbrc.2009.05.038. View

Zucker S, Cao J . Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: ready for prime time?. Cancer Biol Ther. 2009; 8(24):2371-3. PMC: 2829367. DOI: 10.4161/cbt.8.24.10353. View

Poudel B, Ki H, Luyen B, Lee Y, Kim Y, Kim D . Triticumoside induces apoptosis via caspase-dependent mitochondrial pathway and inhibits migration through downregulation of MMP2/9 in human lung cancer cells. Acta Biochim Biophys Sin (Shanghai). 2016; 48(2):153-60. DOI: 10.1093/abbs/gmv124. View

10.

Kumar D, Sundaree S, Johnson E, Shah K . An efficient synthesis and biological study of novel indolyl-1,3,4-oxadiazoles as potent anticancer agents. Bioorg Med Chem Lett. 2009; 19(15):4492-4. DOI: 10.1016/j.bmcl.2009.03.172. View

11.

Nuti E, Cuffaro D, DAndrea F, Rosalia L, Tepshi L, Fabbi M . Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors. ChemMedChem. 2016; 11(15):1626-37. DOI: 10.1002/cmdc.201600235. View

12.

Kumar D, Patel G, Johnson E, Shah K . Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles. Bioorg Med Chem Lett. 2009; 19(10):2739-41. DOI: 10.1016/j.bmcl.2009.03.158. View

13.

Eide H, Halvorsen A, Sandhu V, Fane A, Berg J, Haakensen V . Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease. Clin Transl Immunology. 2016; 5(11):e109. PMC: 5133367. DOI: 10.1038/cti.2016.65. View

14.

Haider S, Alam M, Hamid H . 1,3,4-Thiadiazoles: a potent multi targeted pharmacological scaffold. Eur J Med Chem. 2015; 92:156-77. DOI: 10.1016/j.ejmech.2014.12.035. View

15.

Gregory A, Houghton A . Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011; 71(7):2411-6. DOI: 10.1158/0008-5472.CAN-10-2583. View

16.

Kang L, Hao X, Tang Y, Wei X, Gong Y . RABEX-5 overexpression in gastric cancer is correlated with elevated MMP-9 level. Am J Transl Res. 2016; 8(5):2365-74. PMC: 4891449. View

17.

Patel N, Purohit A, Rajani D, Moo-Puc R, Rivera G . New 2-benzylsulfanyl-nicotinic acid based 1,3,4-oxadiazoles: their synthesis and biological evaluation. Eur J Med Chem. 2013; 62:677-87. DOI: 10.1016/j.ejmech.2012.12.055. View

18.

Gil M, Kim Y, Kim K, Kim W, Park C, Lee K . Cellular prion protein regulates invasion and migration of breast cancer cells through MMP-9 activity. Biochem Biophys Res Commun. 2016; 470(1):213-219. DOI: 10.1016/j.bbrc.2016.01.038. View

19.

Fingleton B . MMPs as therapeutic targets--still a viable option?. Semin Cell Dev Biol. 2007; 19(1):61-8. PMC: 2677300. DOI: 10.1016/j.semcdb.2007.06.006. View

20.

Popiolkiewicz J, Polkowski K, Skierski J, Mazurek A . In vitro toxicity evaluation in the development of new anticancer drugs-genistein glycosides. Cancer Lett. 2005; 229(1):67-75. DOI: 10.1016/j.canlet.2005.01.014. View